tracken
Merck & Co. Aktie News
Positiv
24/7 Wall Street
●
40 Minuten alt
Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open.
Neutral
Seeking Alpha
●
ein Tag alt
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Positiv
Forbes
●
5 Tage alt
Merck (MRK)'s stock surged by 41% in the last six months, driven not only by a modest revenue increase but also by a significant profit jump and heightened investor confidence.
Neutral
Business Wire
●
6 Tage alt
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Second-Quarter 2026 Dividend.
Positiv
The Motley Fool
●
6 Tage alt
Novo Nordisk could see stronger financial results this year thanks to new launches and label expansions. Merck's clinical progress this year could show that it will expertly overcome a major upcoming patent cliff.
Positiv
Seeking Alpha
●
7 Tage alt
GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners
AD HOC NEWS
●
8 Tage alt
Der US-Pharmakonzern Merck & Co US58933Y1055 hat Gespräche zur Übernahme des Biotech-Unternehmens Revolution Medicines US76155X1000 einem Pressebericht zufolge beendet.
Negativ
Reuters
●
8 Tage alt
Merck is no longer in discussions to buy cancer drug developer Revolution Medicines , the Wall Street Journal reported on Sunday.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
